Robert Feldman work email
- Valid
- Valid
- Valid
- Valid
Robert Feldman personal email
- Valid
Biotech executive, board member and advisor with experience and demonstrated success founding startups, working in rapidly scaling growth companies leading to IPOs and helping position large international companies moving through M&As. Exceptional relationship builder, networker to investors, VCs, technical experts, strategic partners and team builders. Domain and leadership expertise in complex multi-stakeholder biotech, diagnostics, genomics, bioinformatics, product development, marketing, sales and support programs. Business acumen in strategy and corporate development. Excels in high stress dynamic environments and situations where pragmatic leadership and decision making is essential.CORE COMPETENCIES AND SKILLSBiotech executive: Startup formation, vision creation, fund raising, value creation, hiring, leading and managing diverse teams of scientists, marketing/sales forces from company inception through R&D to product/service specification launch, sales, growth and support. Strategic business development: Extensive network of investors, technical experts, strategic partners. Skilled in competitive analysis and positioning, identification of complementary technologies, deal structuring, negotiation and deal closing for corporate development.Domain expertise: Business development, strategy, competitive analysis, operations, investor relations, board management, program management and development of diagnostics, biotech, genomics, NGS, bioinformatics programs to applications, products and services for medical genetics and cancer, clinical collaborations, diagnostics, microbiome.PublicationsIn several roles I have built world class teams initiating and leading collaborations bridging academic KOLs to the company. Our work in microbial genomics of deep sea hydrothermal vent organisms, ecological metagenomics and human microbiomics resulted in seminal, high profile, high impact works co-authored and published in Nature, Science and PNAS. From a list of over 40 publications, (according to Google Scholar), these publications have over 12,000 citations; 18 have over 100, 4 have over 1,000 and 1 has been cited more than 5,300 times.
-
Senior Vice President, Business Development And Strategic InitiativesFluxus Inc. Oct 2022 - PresentSunnyvale, California, UsFluxus is developing and commercializing biochip-based, opto-fluidic, single molecule detection platforms for ultra-high sensitivity diagnostics and biosensor applications. Fluxus was recently acquired by, and is now a wholly owned subsidiary of Fujirebio Inc, a global leader and historical pioneer in high performance IVD and clinical diagnostics. Our initial focus areas at Fluxus include neurology, oncology, and infectious disease. I am leading business development and corporate strategy bringing our technology to market. -
Senior AdvisorFluxus Inc. Mar 2022 - Oct 2022Sunnyvale, California, UsProvided strategic advising to the CEO. -
Member Board Of DirectorsRealseq Biosciences Oct 2022 - PresentSanta Cruz, California, UsRealSeq’s industry leading small RNA and miRNA NGS library technology allows broad detection with “best in class” low bias. The company have commercialized a wide range of sequencing services including library preparation from extracted RNA or ready-to-sequence pooled libraries, bioinformatic and reagent kits. The company has raised their first funding round (over subscribed) and is expanding and scaling. Happy to connect interested parties with the team. -
Advisor, Life SciencesSilicon Catalyst Mar 2023 - PresentSanta Clara, Ca, UsSilicon Catalyst is the world’s only incubator + accelerator focused on semiconductor solutions, including Photonics, MEMS, sensors, IP, materials and Life Science. We accelerate startups from idea through prototype, and onto a path to volume production. I am advising on applicant companies in the life sciences. -
Strategic AdvisorS2 Genomics Apr 2021 - PresentLivermore, California, UsS2 Genomics enables automated processing of raw tissues into single cells or nuclei for genomics and cell biology studies. I am advising the CEO and CSO on business and corporate development. -
Strategic AdvisorBuzzkill Labs Mar 2021 - Nov 2021Livermore, California, UsBuzzkill Labs is modernizing drug testing for a world of legal cannabis by developing innovative technology combining noninvasive sampling with sensitive detection and quantitation. I provided strategic advising to the founder, lead investor and board. -
President And CeoPrime Genomics Jan 2015 - Oct 2020Prime Genomics (morphed into AeenaDx, merged with NowDx) was a noninvasive disease diagnostic company focused on transforming breast cancer screening. I took on the company at a critical time and navigated through key hiring, R&D, product specification, fund raising and operation commencement including remote clinical sample collection. Recruited by the lead VC investor and hired by the board as President and CEO, I raised Series A funding and led the company through the Series A milestones and deliverables.
-
Vp Business DevelopmentCentrillion Biosciences, Inc. Feb 2010 - Jan 2015Palo Alto, California, UsWithin Centrillion, I founded and ran an Illumina based genomics and bioinformatics service business as General Manager with P&L responsibilities. Led all aspects of sales, marketing, product/service development, project management, customer support. Services included exome sequencing, RNAseq, whole genomes, GWAS on microarray systems, bioinformatics analyses and support. -
President And CeoSymbio Corporation Jul 2003 - Dec 2009I founded SymBio as a $3.5M spinoff from Amersham Biosciences via bootstrapping contracts. SymBio was a genomics service partner for academic, medical and industrial researchers. Led grants as PI and administrator of NSF, NIH awards and sub awards, PI on deep-sea metagenomics projects, medical projects including lung cancer RNA sequencing, HIV sequencing, gut microbiomes.
-
Adjunct Associate ProfessorUniversity Of Delaware 2002 - 2006Newark, De, UsMetagenomic studies of microbial populations of deep sea hydrothermal vent associated microbes. -
Collaborations Manager, Genomics Applications DevelopmentMolecular Dynamics (Acquired By Amersham Biosciences, Ge Healthcare, Cytiva, Danaher) May 1999 - May 2003I founded the high-throughput genomic lab conducting high visibility R&D projects for alpha and beta testing of DNA seq and bioinformatics platforms. Provided marketing and sales support of MegaBACE instruments, TempliPhi reagents, and Cimarron SW platforms for high throughput genomics customers (JGI, Wash U, Whitehead, BGI, UWash, Baylor). Our platforms powered the sequencing of the human genome and contributed to the $9.5B acquisition by GEHC in 2003
-
Staff Scientist, GenomicsDiversa Corporation (Verenium --> Basf) 1997 - 1999Diversa was a groundbreaking genomics and bioinformatics development company creating and mining environmental metagenomic expression libraries for enzymes for pharmaceutical, agriculture, chemical processing, oil production, etc. Participated in >$200M IPO, at that time, the largest ever for a genomics tools company. I co-developed company wide bioinformatics platform was project leader on comparative environmental genomics and key conference presenter on early bacterial genome projects resulting in worldwide press coverage.
-
Research Assistant ProfessorRutgers University 1994 - 1997New Brunswick, Nj, UsGenetic studies of microbial symbionts of deep sea hydrothermal vent invertebrates
Robert Feldman Skills
Robert Feldman Education Details
-
University Of Hawaii At ManoaGenetics -
University Of Illinois Urbana-ChampaignGeneral
Frequently Asked Questions about Robert Feldman
What company does Robert Feldman work for?
Robert Feldman works for Fluxus Inc.
What is Robert Feldman's role at the current company?
Robert Feldman's current role is Biotech Executive/Advisor/Entrepreneur.
What is Robert Feldman's email address?
Robert Feldman's email address is rf****@****ics.com
What schools did Robert Feldman attend?
Robert Feldman attended University Of Hawaii At Manoa, University Of Illinois Urbana-Champaign.
What are some of Robert Feldman's interests?
Robert Feldman has interest in Children, Economic Empowerment, Education, Environment, Science And Technology, Human Rights, Animal Welfare, Arts And Culture, Health.
What skills is Robert Feldman known for?
Robert Feldman has skills like Genomics, Biotechnology, Bioinformatics, Dna Sequencing, Genetics, Commercialization, R&d, Microbiology, Lifesciences, Life Sciences, Product Development, Management.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial